European Archives - Page 203 of 1213 - European Medical Journal

Charl van Zyl, Lundbeck Pharmaceuticals

Lundbeck’s Charl van Zyl on a new era in neurology

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.

Deep-Learning Model for Lung Tumour Detection and Segmentation

Novel deep-learning model has shown promise in identifying and segmenting lung tumours according to new research.

The Role of Antimicrobials and Vaccines in Reducing Dementia Risk

Data review suggests antibiotics, vaccines, and anti-inflammatory drugs reduce dementia risk, advancing drug repurposing opportunities.

Low Lymphocyte Count Linked to Poorer Survival in Multiple Myeloma

Low lymphocyte count at diagnosis and during treatment is associated with poorer survival in multiple myeloma patients.

GLP-1 Receptor Agonists Linked to Behavioural Side Effects

Diabetes treatments linked to behavioural side effects in new research.

Comparing Infant Formulas for Cow’s Milk Protein Allergy

Hydrolysed rice formulas offer unique advantages, such as accommodating cultural, religious, and economic preferences.

Advancing Haemophilia Care: An EAHAD Roundtable Discussion

Tune into the latest EMJ Webinar, featuring five key members of the European Association for Haemophilia and Allied Disorders (EAHAD), who join Jonathan Sackier to discuss the EAHAD’s mission, aims, and key projects for the coming year.

Electronic Noses and Breath Profiles for Diagnosing Disease

This infographic highlights the transformative potential of electronic noses (eNoses) in disease diagnosis, monitoring, and treatment…

GSK and Oxford unite to advance cancer vaccine research

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

Health Disparities in MASLD Among Hispanic Adults

Data from 22 studies, encompassing 756,088 subjects, including 62,072 Hispanic adults, revealed striking findings.